Drug recall · April 10, 2019
8.4% Sodium Bicarbonate Injection recall
Why: Presence of Particulate Matter; glass particulates
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
8.4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL) 50 mL Single-dose fliptop vial, 25 vials per carton, Rx only Hospira, Inc. Lake Forest, IL 60045 USA ---- NDC 0409-6625-02
- Lots / codes
Lots: 79-238-EV Exp. 1 July 2019; 79-240-EV Exp. 1 July 2019; 80-088-EV Exp. 1 August 2019
- Quantity
- 283,400 vials
- Company
- Pfizer Inc., New York, NY
- Distribution
- United States and Puerto Rico
- Initiated
- March 15, 2019 · Voluntary: Firm initiated
- Classified
- March 29, 2019
- Reported
- April 10, 2019
- Ended
- January 27, 2021
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sodium bicarbonate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.